Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy

OBJECTIVE: To determine if prenatal exposure to methylphenidate (MPH) or atomoxetine (ATX) increases the risk of adverse pregnancy outcomes in women with attention deficit/hyperactivity disorder (ADHD). MATERIALS AND METHODS: This was a population-based cohort study of all pregnancies in Denmark fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bro, Søren Pauli, Kjaersgaard, Maiken Ina Siegismund, Parner, Erik Thorlund, Sørensen, Merete Juul, Olsen, Jørn, Bech, Bodil Hammer, Pedersen, Lars Henning, Christensen, Jakob, Vestergaard, Mogens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317061/
https://www.ncbi.nlm.nih.gov/pubmed/25657597
http://dx.doi.org/10.2147/CLEP.S72906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317061/
https://www.ncbi.nlm.nih.gov/pubmed/25657597
http://dx.doi.org/10.2147/CLEP.S72906

Ejemplares similares